Dapagliflozin 10mg Tab Clinical Trials
16 recruitingDrug
Phase 46Phase 25Phase 34Not Applicable1Phase 11
Showing 1–16 of 16 trials
Recruiting
Phase 4
SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus
Chronic Hepatitis B
Chinese University of Hong Kong412 enrolled1 locationNCT06364930
Recruiting
Phase 2
Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal Syndrome
Heart FailureAcute Kidney Injury
Yale University130 enrolled2 locationsNCT07273838
Recruiting
Phase 2Phase 3
Activation of Autophagy and Suppression of Apoptosis by Dapagliflozin Attenuates Inflammatory Bowel Disease
Inflammatory Bowel Diseases
Mostafa Bahaa50 enrolled1 locationNCT05986136
Recruiting
Phase 4
A Randomized, Placebo-controlled Trial of DAPAgliflozin (DAPA) for Cardiovascular Risk Reduction in the Postpartum Period of Hypertensive Pregnancies (HP)
Cardiovascular ComplicationPre-EclampsiaGestational Hypertension+2 more
University of Michigan200 enrolled1 locationNCT06785116
Recruiting
Phase 3
Dapagliflozin in STEMI
Myocardial InfarctionST Elevation Myocardial Infarction
Ottawa Heart Institute Research Corporation256 enrolled1 locationNCT06174753
Recruiting
Phase 4
Cardiotoxicity in Breast Cancer Patients
Breast Cancer
Helwan University40 enrolled1 locationNCT06491680
Recruiting
Phase 1
Effect of Dapagliflozin on Microvascular Function in Women With Symptoms of Coronary Artery Disease
Myocardial Ischemia
University of Virginia40 enrolled1 locationNCT05762952
Recruiting
Phase 4
Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients
DiabetesKidney Transplant; ComplicationsVascular Diseases
University of Colorado, Denver80 enrolled1 locationNCT06140537
Recruiting
Phase 2
A Study to Investigate the Mechanistic Effects of Dapagliflozin Alone or in Combination With Balcinrenone, Compared to Balcinrenone and Placebo on Body Fluid and Electrolyte Handling and Energy Metabolism in Participants Over 50 Years of Age With Chronic Kidney Disease.
Chronic Kidney Disease Stage 3Chronic Renal FailureMechanistic Effects of SGLT2 Inhibition and/ or MR Antagonism on Body Fluid and Electrolyte Homeostatis+1 more
Klinikum Nürnberg100 enrolled2 locationsNCT05884866
Recruiting
Phase 3
SGLT2 Inhibitor TrEatment iN Patients Awaiting cOronary arTery bYpass Surgery to Reduce Post-opErative AF
Atrial FibrillationChronic Coronary Syndrome
Region Örebro County800 enrolled8 locationsNCT05852704
Recruiting
Phase 4
Can Dapagliflozin Preserve Structure and Function in Transplanted Kidneys?
Kidney Transplant; ComplicationsRenal FailureKidney Transplant Failure
Oslo University Hospital330 enrolled1 locationNCT05788276
Recruiting
Phase 2
SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease
Chronic Kidney DiseasesLupus Nephritis
The University of Hong Kong150 enrolled1 locationNCT06155604
Recruiting
Phase 4
Dapagliflozin on Renal Morphology and Renal Perfusion in Patients One Year After Kidney Transplantation
Chronic Kidney Diseases
University of Erlangen-Nürnberg Medical School48 enrolled1 locationNCT06560801
Recruiting
Phase 3
Renoprotective Effects of Dapagliflozin Versus Pentoxiphylline in Chronic Kidney Disease Patients
Chronic Kidney Diseases
Ain Shams University210 enrolled1 locationNCT06421870
Recruiting
Phase 2
Potential Protective Role of SGLT-2 Inhibitors for Chemotherapy-induced Cardiotoxicity
Breast Cancer
Fondazione IRCCS Policlinico San Matteo di Pavia316 enrolled1 locationNCT06341842
Recruiting
Not Applicable
Clinical Investigation of the Cardioprotective Effect of Early Administration of SGLT2 in Patients Presented With AMI
Myocardial Infarction
Mohammad Hussien Tantawy Soliman80 enrolled1 locationNCT06009874